Burden of systemic lupus erythematosus in Taiwan: a population-based survey

被引:54
作者
Yeh, Kuo-Wei [1 ,2 ]
Yu, Chong-Hua [3 ,4 ]
Chan, Pei-Chun [1 ,2 ]
Horng, Jorng-Tzong [3 ,4 ]
Huang, Jing-Long [1 ,2 ]
机构
[1] Chang Gung Univ, Div Pediat Allergy Asthma & Rheumatol, Dept Pediat, Chang Gung Mem Hosp Linkuo, Tao Yuan, Taiwan
[2] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan
[3] Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli 32001, Taoyuan County, Taiwan
[4] Asia Univ, Dept Biomed Informat, Taichung 41354, Taiwan
关键词
Epidemiology; Incidence; Mortality; Systemic lupus erythematosus; CHINESE POPULATION; CLINICAL-FEATURES; EPIDEMIOLOGY; MORTALITY; DISEASE; PREVALENCE; SURVIVAL;
D O I
10.1007/s00296-012-2643-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This population-based study aimed to determine the trend of incidence, prevalence, and mortality of systemic lupus erythematosus (SLE) in a 6-year period in Taiwan. Patients with international classification of diseases ninth revision (ICD-9) code 710.0 were retrieved from the Taiwanese National Health Insurance Research Database (NHIRD), which covered more than 96 % of the entire population, and from the Ministry of Interior between 2003 and 2008 in Taiwan. Patients with SLE registered as catastrophic illness were enrolled for analysis. The incidence rate, prevalence ratio, and mortality rate stratified by sex and age were analyzed. There were a total of 6,675 SLE patients (5,836 females and 839 in males) during the study period. The average annual incidence rate was 4.87 per 100,000 population, and the average female-to-male incidence ratio was 7.15. The ratio increased with age and peaked at the age of 40-49 years, then decreased thereafter. The incidence rate decreased by 4.2 % per year. The highest incidence rate was noted in the 20-29-year-old age group in females and the 70-79-year-old age group in males. The average prevalence and mortality rates were 97.5 and 1.2 per 100,000 population, respectively. Mortality was 3.2 % in patients diagnosed within 1 year and is more prevalent in young patients with average age of 15.6 years. Incidence rate of SLE has been declining in recent years but the prevalence rate has remained steady. The highest mortality rate is among younger patients diagnosed with SLE within 1 year.
引用
收藏
页码:1805 / 1811
页数:7
相关论文
共 23 条
[1]   Mortality in systemic lupus erythematosus [J].
Bernatsky, S. ;
Boivin, J. -F. ;
Joseph, L. ;
Manzi, S. ;
Ginzler, E. ;
Gladman, D. D. ;
Urowitz, M. ;
Fortin, P. R. ;
Petri, M. ;
Barr, S. ;
Gordon, C. ;
Bae, S. -C. ;
Isenberg, D. ;
Zoma, A. ;
Aranow, C. ;
Dooley, M. -A. ;
Nived, O. ;
Sturfelt, G. ;
Steinsson, K. ;
Alarcon, G. ;
Senecal, J. -L. ;
Zummer, M. ;
Hanly, J. ;
Ensworth, S. ;
Pope, J. ;
Edworthy, S. ;
Rahman, A. ;
Sibley, J. ;
El-Gabalawy, H. ;
McCarthy, T. ;
Pierre, Y. St. ;
Clarke, A. ;
Ramsey-Goldman, R. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2550-2557
[2]   The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe [J].
Cervera, R. ;
Khamashta, M. A. ;
Hughes, G. R. V. .
LUPUS, 2009, 18 (10) :869-874
[3]   The clinical features and prognosis of male lupus in Taiwan [J].
Chang, DM ;
Chang, CC ;
Kuo, SY ;
Chu, SJ ;
Chang, ML .
LUPUS, 1998, 7 (07) :462-468
[4]   Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up [J].
Chen, M. -J. ;
Tseng, H. -M. ;
Huang, Y. -L. ;
Hsu, W. -N. ;
Yeh, K. -W. ;
Wu, T. -L. ;
See, L. -C. ;
Huang, J. -L. .
RHEUMATOLOGY, 2008, 47 (09) :1352-1357
[5]   Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan [J].
Chiu, Y-M ;
Lai, C-H .
LUPUS, 2010, 19 (10) :1250-1255
[6]   Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy [J].
Eilertsen, Gro Ostli ;
Fismen, Silje ;
Hanssen, Tor-Arne ;
Nossent, Johannes C. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (02) :620-627
[7]  
FESSEL WJ, 1988, RHEUM DIS CLIN N AM, V14, P15
[8]  
Fujukawa S, 1997, ACTA PAEDIATR JAPON, V39, P242
[9]  
Huang JL, 2004, CLIN EXP RHEUMATOL, V22, P776
[10]  
Johnson SR, 2006, J RHEUMATOL, V33, P1990